eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 16/01/2012
PIL Cardioxane 500mg powder for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Changes to therapeutic indications
Updated on 12/08/2011 and displayed until 16/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 17/08/2010 and displayed until 12/08/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 18/11/2009 and displayed until 17/08/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change due to user-testing of patient information
Updated on 16/09/2009 and displayed until 18/11/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/08/2007 and displayed until 16/09/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  dexrazoxane hydrochloride